AVCURI Trademark

Trademark Overview


On Tuesday, December 30, 2025, a trademark application was filed for AVCURI with the United States Patent and Trademark Office. The USPTO has given the AVCURI trademark a serial number of 99570917. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, May 5, 2026. This trademark is owned by Actinium Pharmaceuticals, Inc.. The AVCURI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; Pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations for the treatment of cancer
avcuri

General Information


Serial Number99570917
Word MarkAVCURI
Filing DateTuesday, December 30, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, May 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; Pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameActinium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
US

Trademark Events


Event DateEvent Description
Tuesday, December 30, 2025NEW APPLICATION ENTERED
Tuesday, December 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 30, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, April 29, 2026ASSIGNED TO EXAMINER
Tuesday, May 5, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 5, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, May 5, 2026APPROVED FOR PUB - PRINCIPAL REGISTER